Zobrazeno 1 - 10
of 75
pro vyhledávání: '"D. Geijsen"'
Publikováno v:
Radiation Oncology, Vol 15, Iss 1, Pp 1-9 (2020)
Abstract Background To compare online adaptive radiation therapy (ART) to a clinically implemented plan selection strategy (PS) with respect to dose to the organs at risk (OAR) for rectal cancer. Methods The first 20 patients treated with PS between
Externí odkaz:
https://doaj.org/article/b222001d86954f5596e6b6f8ff3f5d88
Publikováno v:
Radiation Oncology, Vol 15, Iss 1, Pp 1-11 (2020)
Abstract Background To compare target coverage and dose to the organs at risk in two approaches to rectal cancer: a clinically implemented adaptive radiotherapy (ART) strategy using plan selection, and a non-adaptive (non-ART) strategy. Methods The i
Externí odkaz:
https://doaj.org/article/db1e680d168240a7a9309d408f49b9ac
Autor:
Marieke Pape, Linde M. Veen, Thom M. Smit, Steven C. Kuijper, Pauline A.J. Vissers, Elisabeth D. Geijsen, Peter S.N. van Rossum, Mirjam A.G. Sprangers, Sarah Derks, Rob H.A. Verhoeven, Hanneke W.M. van Laarhoven
Publikováno v:
Pape, M, Veen, L M, Smit, T M, Kuijper, S C, Vissers, P A J, Geijsen, E D, van Rossum, P S N, Sprangers, M A G, Derks, S, Verhoeven, R H A & van Laarhoven, H W M 2023, ' Late Toxicity and Health-Related Quality of Life Following Definitive Chemoradiotherapy for Esophageal Cancer : A Systematic Review and Meta-analysis ', International Journal of Radiation Oncology Biology Physics . https://doi.org/10.1016/j.ijrobp.2023.05.025
Purpose: Definitive chemoradiotherapy (dCRT) is a treatment option with curative intent for patients with esophageal cancer that could result in late toxicities and affect health-related quality of life (HRQoL). This study aimed to review the literat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::91d86235c7072466b2ff705aae970e42
https://research.vumc.nl/en/publications/3e030dd4-63ec-4136-964a-39eb062a903e
https://research.vumc.nl/en/publications/3e030dd4-63ec-4136-964a-39eb062a903e
Autor:
Hanneke W. M. van Laarhoven, Elisabeth D. Geijsen, Paul M. Jeene, Mark I. van Berge Henegouwen, Adriana Thano, Joost J. Nuyttens, Vera Oppedijk, Maarten C.C.M. Hulshof, Maurice J.C. van der Sangen, Karen J. Neelis, Jannie G Reinders, Ate van der Gaast, Jeanin E. van Hooft, Tom Rozema, Jeroen Buijsen
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 39(25), 2816-2824. American Society of Clinical Oncology
Journal of Clinical Oncology, 39(25), 2816-+. American Society of Clinical Oncology
Journal of clinical oncology, 39(25), 2816-2824. American Society of Clinical Oncology
Journal of Clinical Oncology, 39(25), 2816-+. American Society of Clinical Oncology
Journal of clinical oncology, 39(25), 2816-2824. American Society of Clinical Oncology
PURPOSE To analyze the effect of radiation dose escalation to the primary tumor on local tumor control in definitive chemoradiation (dCRT) for patients with esophageal cancer. PATIENTS AND METHODS Patients with medically inoperable and/or irresectabl
Autor:
Richard van Hillegersberg, Tom van den Ende, Sybren L. Meijer, Rob H.A. Verhoeven, Max Nieuwdorp, Mark P. G. Dings, Nadia Haj Mohammad, Tanja D. de Gruijl, Nicolien C. de Clercq, H.W.M. van Laarhoven, Jacques J. Bergman, Elisabeth D. Geijsen, Stella Mook, Sandor Schokker, Maarten C.C.M. Hulshof, Nicole C.T. van Grieken, Maarten F. Bijlsma, Bauke Ylstra, Jelle P. Ruurda, Mark I. van Berge Henegouwen, Suzanne S. Gisbertz, Tanya T.D. Soeratram
Publikováno v:
van den Ende, T, Clercq, N D, van Berge Henegouwen, M I, Gisbertz, S S, Geijsen, D, Verhoeven, R, Meijer, S L, Schokker, S, Dings, M, Bergman, J J G H M, Haj Mohammad, N, Ruurda, J P, van Hillegersberg, R, Mook, S, Nieuwdorp, M, de Gruijl, T D, Soeratram, T T D, Ylstra, B, van Grieken, N C T, Bijlsma, M F, Hulshof, M C C M & van Laarhoven, H W 2021, ' Neoadjuvant Chemoradiotherapy Combined with Atezolizumab for Resectable Esophageal Adenocarcinoma : A Single Arm Phase II Feasibility Trial (PERFECT) ', Clinical cancer research : an official journal of the American Association for Cancer Research, vol. 27, no. 12, pp. 3351-3359 . https://doi.org/10.1158/1078-0432.CCR-20-4443
Clinical cancer research : an official journal of the American Association for Cancer Research, 27(12), 3351-3359. American Association for Cancer Research Inc.
Clinical cancer research, 27(12), 3351-3359. American Association for Cancer Research Inc.
Clin Cancer Res
Clinical cancer research : an official journal of the American Association for Cancer Research, 27(12), 3351-3359. American Association for Cancer Research Inc.
Clinical cancer research, 27(12), 3351-3359. American Association for Cancer Research Inc.
Clin Cancer Res
Purpose: The CROSS trial established neoadjuvant chemoradiotherapy (nCRT) for patients with resectable esophageal adenocarcinoma (rEAC). In the PERFECT trial, we investigated the feasibility and efficacy of nCRT combined with programmed-death ligand-
Autor:
K.F. Crama, Jorrit Visser, Jan Wiersma, R. De Jong, Elisabeth D. Geijsen, N. Van Wieringen, Arjan Bel
Publikováno v:
Radiation Oncology, Vol 15, Iss 1, Pp 1-11 (2020)
Radiation oncology (London, England), 15(1):13. BioMed Central
Radiation Oncology (London, England)
Radiation oncology (London, England), 15(1):13. BioMed Central
Radiation Oncology (London, England)
Background To compare target coverage and dose to the organs at risk in two approaches to rectal cancer: a clinically implemented adaptive radiotherapy (ART) strategy using plan selection, and a non-adaptive (non-ART) strategy. Methods The inclusion
Autor:
Anne M. Stiggelbout, Yvette M. van der Linden, Arwen H. Pieterse, M. C. M. Baas-Thijssen, Karin Muller, Marleen Kunneman, Heleen M. Ceha, Elisabeth D. Geijsen, Corrie A.M. Marijnen, Wilbert B. van den Hout
Publikováno v:
Acta Oncologica, 1-8
STARTPAGE=1;ENDPAGE=8;TITLE=Acta Oncologica
Acta oncologica (Stockholm, Sweden), 58(7), 1069-1076. Informa Healthcare
STARTPAGE=1;ENDPAGE=8;TITLE=Acta Oncologica
Acta oncologica (Stockholm, Sweden), 58(7), 1069-1076. Informa Healthcare
Introduction: Patient preferences are often not discussed in treatment decisions in oncology. We introduced an online values clarification method (VCM) to help newly diagnosed rectal cancer patients participate in shared decision making about short-c
Autor:
H. P. Kok, Elisabeth D. Geijsen, A. Bakker, Johannes Crezee, Maarten C.C.M. Hulshof, T.M. De Reijke, G. Schooneveldt
Publikováno v:
International journal of hyperthermia, 35(1), 441-449. Informa Healthcare
Purpose: Loco-regional hyperthermia combined with mitomycin C is used for treatment of nonmuscle invasive bladder cancer (NMIBC). Air pockets may be present in the bladder during treatment. The aim of this study is to quantify the effect of air pocke
Autor:
Jan Wiersma, R. De Jong, Elisabeth D. Geijsen, Jorrit Visser, Arjan Bel, K.F. Crama, N. Van Wieringen
Publikováno v:
Radiation oncology (London, England), 15(1):162. BioMed Central
Radiation Oncology, Vol 15, Iss 1, Pp 1-9 (2020)
Radiation Oncology (London, England)
Radiation Oncology, Vol 15, Iss 1, Pp 1-9 (2020)
Radiation Oncology (London, England)
Background To compare online adaptive radiation therapy (ART) to a clinically implemented plan selection strategy (PS) with respect to dose to the organs at risk (OAR) for rectal cancer. Methods The first 20 patients treated with PS between May–Sep
Additional file 3. Patient characteristics.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2df8a5238f199e77ce0bb50fd44d89b1